Intravitreal Ranibizumab in Retinal Pigment Epithelial Detachments

Inclusion Criteria: * patients with age-related macular degeneration and serous pigment epithelial detachment as determined by fluorescein and indocyanine green angiography and optical coherence tomography (OCT) * patients who have a best-corrected visual acuity (BCVA) score between 73 and 24 ETDRS letters * patients with pigment epithelial detachment (PED) ≥ 200 µm as determined by OCT * male or female patients 50 years of age or greater * patients willing and able to comply with all study procedures Exclusion Criteria: * patients with best-corrected visual acuity (BCVA) \< 24 or \>73 letters in the study eye * patients previously treated by intravitreal injections of steroids or anti-VEGF agents, or patients previously treated by Verteporfin photodynamic therapy or focal laser photocoagulation * history of uncontrolled glaucoma in the study eye